+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nuclear Medicine Market by Product, Application, Type, End-Users - Global Forecast 2025-2030- Product Image
Nuclear Medicine Market by Product, Application, Type, End-Users - Global Forecast 2025-2030- Product Image
Sale

Nuclear Medicine Market by Product, Application, Type, End-Users - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5206422
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Nuclear Medicine Market grew from USD 5.14 billion in 2023 to USD 5.51 billion in 2024. It is expected to continue growing at a CAGR of 7.35%, reaching USD 8.45 billion by 2030.

Nuclear Medicine is an innovative field that involves the use of radioactive substances for diagnosis, treatment, and research. It primarily encompasses two segments: diagnostic techniques such as PET and SPECT scans, and therapeutic applications like radiotherapy for cancer treatment. The market for nuclear medicine is driven by the rising prevalence of chronic diseases, particularly cancers and neurological disorders, necessitating advanced diagnostic tools and personalized treatment options. Its applications extend into cardiology, oncology, neurology, and endocrinology, available across hospitals, diagnostic labs, and research institutes. Growth is further influenced by technological advancements, such as the development of novel radiopharmaceuticals and the integration of AI in imaging processes. Opportunities lie in expanding research on targeted alpha therapies (TAT) and the development of hybrid imaging technologies, given the rising demand for precision medicine. However, market growth is challenged by high costs of equipment and procedures, stringent regulatory requirements for drug approval, and limited availability of certain radioisotopes. Additionally, the requirement for skilled personnel and concerns regarding radiation exposure pose significant limitations. Innovation should focus on optimizing production and supply chains of radioisotopes, improving the safety and efficiency of radiopharmaceuticals, and developing less invasive diagnostic techniques. Enhanced collaboration between public institutions and private companies could foster innovation and streamline regulatory pathways. Climate-sensitive regions present further opportunities, where healthcare systems are prioritizing early diagnostic tech solutions. As competition intensifies, companies should invest in R&D to diversify product lines and collaborate with tech firms to integrate AI and machine learning capabilities. The market is highly dynamic, marked by rapid advancements and periodic disruptions, with emerging markets presenting new growth areas due to increasing healthcare investments and awareness about nuclear medicine's capabilities.

Understanding Market Dynamics in the Nuclear Medicine Market

The Nuclear Medicine Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising Incidence and Prevalence of Cancer Worldwide
    • Increasing Use of PET and SPECT to Diagnose Heart disease and Neurological Disorders
    • International Organizations’ Initiatives and Awareness Supporting Nuclear Medicine
  • Market Restraints
    • Shorter Half-Life of Nuclear Medicine
  • Market Opportunities
    • Emerging Popularity of Theranostics in Nuclear Medicine
    • Continuous Product Developments and Advancements in Patented Technologies
  • Market Challenges
    • Lack of Knowledge, Training, and Availability of Nuclear Medicine in Developing Countries
    • Limited Availability of Skilled Radiologists and Practitioners Worldwide

Exploring Porter’s Five Forces for the Nuclear Medicine Market

Porter’s Five Forces framework further strengthens the insights of the Nuclear Medicine Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Nuclear Medicine Market

External macro-environmental factors deeply influence the performance of the Nuclear Medicine Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Nuclear Medicine Market

The Nuclear Medicine Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Nuclear Medicine Market

The Nuclear Medicine Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the Nuclear Medicine Market, highlighting leading vendors and their innovative profiles. These include Actinium Pharmaceuticals, Inc., Bayer AG, BJ Madan & Co., Bracco S.p.A., BWX Technologies, Inc. by Framatome, Cardinal Health, Inc., Curium, Eckert & Ziegler Radiopharma GmbH, Eczacibaşi Monrol Nuclear Products Co., GE Healthcare, IBA Radiopharma Solutions, Institute of Isotopes Co., Ltd., Isotope Joint Stock Company, Isotopia Molecular Imaging, Jubilant DraxImage, Inc., Lantheus Holdings, Inc., Nordic Nanovector ASA by Thor Medical, Nordion (Canada) Inc. by Sotera Health LLC, Northstar Medical Technologies LLC, Novartis AG, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings LLC, Radiopharm Theranostics Limited, SHINE Technologies, LLC, and Sinotau Pharmaceuticals Group.

Market Segmentation & Coverage

This research report categorizes the Nuclear Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Diagnostic Products
      • PET
        • F-18
        • SR-82/RB-82
      • SPECT
        • GA-67
        • I-123
        • TC-99m
        • TL-201
    • Therapeutic Products
      • Alpha Emitters
      • Beta Emitters
        • I-131
        • Lu-117
        • Re-186
        • SM-153
        • Y-90
      • Brachytherapy
        • Cesium-131
        • Iodine-125
        • Iridium-192
        • Palladium-103
  • Application
    • Bone Metastasis
    • Cardiology
    • Endocrine Tumor
    • Lymphoma
    • Oncology
    • Thyroid
  • Type
    • Diagnostic
      • PET Procedures
      • SPECT Procedures
    • Therapeutic
      • Alpha Emitter Procedures
      • Beta Emitter Procedures
      • Brachytherapy Procedures
  • End-Users
    • Hospitals & Diagnostic Centers
    • Research institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Incidence and Prevalence of Cancer Worldwide
5.1.1.2. Increasing Use of PET and SPECT to Diagnose Heart disease and Neurological Disorders
5.1.1.3. International Organizations’ Initiatives and Awareness Supporting Nuclear Medicine
5.1.2. Restraints
5.1.2.1. Shorter Half-Life of Nuclear Medicine
5.1.3. Opportunities
5.1.3.1. Emerging Popularity of Theranostics in Nuclear Medicine
5.1.3.2. Continuous Product Developments and Advancements in Patented Technologies
5.1.4. Challenges
5.1.4.1. Lack of Knowledge, Training, and Availability of Nuclear Medicine in Developing Countries
5.1.4.2. Limited Availability of Skilled Radiologists and Practitioners Worldwide
5.2. Market Segmentation Analysis
5.2.1. Product: Significance of diagnostic products in nuclear medicines
5.2.2. End-Users: Diverse applications in hospitals and diagnostic centers
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
5.5. Client Customization
6. Nuclear Medicine Market, by Product
6.1. Introduction
6.2. Diagnostic Products
6.2.1. PET
6.2.1.1. F-18
6.2.1.2. SR-82/RB-82
6.2.2. SPECT
6.2.2.1. GA-67
6.2.2.2. I-123
6.2.2.3. TC-99m
6.2.2.4. TL-201
6.3. Therapeutic Products
6.3.1. Alpha Emitters
6.3.2. Beta Emitters
6.3.2.1. I-131
6.3.2.2. Lu-117
6.3.2.3. Re-186
6.3.2.4. SM-153
6.3.2.5. Y-90
6.3.3. Brachytherapy
6.3.3.1. Cesium-131
6.3.3.2. Iodine-125
6.3.3.3. Iridium-192
6.3.3.4. Palladium-103
7. Nuclear Medicine Market, by Application
7.1. Introduction
7.2. Bone Metastasis
7.3. Cardiology
7.4. Endocrine Tumor
7.5. Lymphoma
7.6. Oncology
7.7. Thyroid
8. Nuclear Medicine Market, by Type
8.1. Introduction
8.2. Diagnostic
8.2.1. PET Procedures
8.2.2. SPECT Procedures
8.3. Therapeutic
8.3.1. Alpha Emitter Procedures
8.3.2. Beta Emitter Procedures
8.3.3. Brachytherapy Procedures
9. Nuclear Medicine Market, by End-Users
9.1. Introduction
9.2. Hospitals & Diagnostic Centers
9.3. Research institutes
10. Americas Nuclear Medicine Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Nuclear Medicine Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Nuclear Medicine Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Shine Reaches Supply Agreement with Nucleus RadioPharma
13.3.2. ITM and Canadian Nuclear Labs Launch New Company
13.3.3. Life Healthcare Set to Acquire Nuclear-medicine Operation in SA
List of Figures
FIGURE 1. NUCLEAR MEDICINE MARKET RESEARCH PROCESS
FIGURE 2. NUCLEAR MEDICINE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 13. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. NUCLEAR MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. NUCLEAR MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. NUCLEAR MEDICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. NUCLEAR MEDICINE MARKET DYNAMICS
TABLE 7. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY F-18, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SR-82/RB-82, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GA-67, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-123, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TC-99M, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TL-201, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-131, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LU-117, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RE-186, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SM-153, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY Y-90, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINE TUMOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THYROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 93. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 95. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 96. CANADA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 97. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 98. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 99. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 100. CANADA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. CANADA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 103. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 104. CANADA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 105. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 107. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 108. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 109. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 110. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 111. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 112. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 115. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 116. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 130. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 145. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 146. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 147. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 148. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 149. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 150. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 155. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 157. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 158. CHINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 159. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 160. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 161. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 162. CHINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. CHINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 165. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 166. CHINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 167. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 169. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 170. INDIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 171. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 172. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 173. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 174. INDIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. INDIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 177. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 178. INDIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 179. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 181. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 182. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 183. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 184. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 185. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 186. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 189. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 190. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 191. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 193. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 194. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 195. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 196. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 197. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 198. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 200. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 201. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 202. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 203. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 205. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 206. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 207. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 208. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 209. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 210. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 212. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 213. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 215. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 217. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 218. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 219. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 220. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 221. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 222. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 224. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 225. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 226. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 227. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 229. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 230. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 231. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 232. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 233. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 234. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 236. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 237. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 238. SINGAPORE NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 239. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 241. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 242. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 243. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 244. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 245. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 246. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 249. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 250. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 251. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 253. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 254. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 255. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 256. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 257. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 258. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 260. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 261. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 262. TAIWAN NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 263. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 264. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 265. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 266. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 267. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 268. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 269. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 270. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 272. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 273. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 274. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 275. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 276. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 277. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 278. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 279. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 280. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 281. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 282. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 284. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 285. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 286. VIETNAM NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 300. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 301. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 302. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 303. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 304. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 305. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 306. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 307. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 308. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 309. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 310. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 311. DENMARK NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 312. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 313. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 314. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 315. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 316. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 317. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 318. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 319. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 321. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 322. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 323. EGYPT NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 324. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 325. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 326. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 327. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 328. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 329. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 330. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 331. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 332. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 333. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 334. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 335. FINLAND NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 336. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 337. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 338. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 339. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 340. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 341. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 342. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 343. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 344. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 345. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 346. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 347. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 348. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 349. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 350. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 351. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 352. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 353. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2030 (USD MILLION)
TABLE 354. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 355. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 356. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 357. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 358. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 359. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 360. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 361. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2030 (USD MILLION)
TABLE 362. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2030 (USD MILLION)
TABLE 363. ISRAEL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2030 (USD MILLION)
TABLE 364. ISRAEL NUCLEAR MEDICINE MARKET SIZE

Companies Mentioned

The leading players in the Nuclear Medicine market, which are profiled in this report, include:
  • Actinium Pharmaceuticals, Inc.
  • Bayer AG
  • BJ Madan & Co.
  • Bracco S.p.A.
  • BWX Technologies, Inc. by Framatome
  • Cardinal Health, Inc.
  • Curium
  • Eckert & Ziegler Radiopharma GmbH
  • Eczacibaşi Monrol Nuclear Products Co.
  • GE Healthcare
  • IBA Radiopharma Solutions
  • Institute of Isotopes Co., Ltd.
  • Isotope Joint Stock Company
  • Isotopia Molecular Imaging
  • Jubilant DraxImage, Inc.
  • Lantheus Holdings, Inc.
  • Nordic Nanovector ASA by Thor Medical
  • Nordion (Canada) Inc. by Sotera Health LLC
  • Northstar Medical Technologies LLC
  • Novartis AG
  • NTP Radioisotopes SOC Ltd.
  • PharmaLogic Holdings LLC
  • Radiopharm Theranostics Limited
  • SHINE Technologies, LLC
  • Sinotau Pharmaceuticals Group

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.51 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.45 Billion
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 170 Pages
  • Global
From
Nuclear Medicine/Radiopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Nuclear Medicine/Radiopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Prostate Cancer Nuclear Medicine Diagnostics Market by Type, Product - Global Forecast 2025-2030 - Product Image

Prostate Cancer Nuclear Medicine Diagnostics Market by Type, Product - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Nuclear Medicine Radioisotopes Market by Product Type, Application, End-User - Global Forecast 2025-2030 - Product Image

Nuclear Medicine Radioisotopes Market by Product Type, Application, End-User - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Nuclear Medicine Equipment Market Size, Share and Trends Analysis Report by Type (SPECT, PET, Planar Scintigraphy Systems), Application (Oncology, Cardiology, Neurology, General Imaging), End-use, and Region 2024-2030 - Product Image

Nuclear Medicine Equipment Market Size, Share and Trends Analysis Report by Type (SPECT, PET, Planar Scintigraphy Systems), Application (Oncology, Cardiology, Neurology, General Imaging), End-use, and Region 2024-2030

  • Report
  • 100 Pages
  • Global
From

About the Nuclear Medicine Market

Nuclear Medicine is a field of medicine that uses radioactive materials to diagnose and treat diseases, particularly cancer. Nuclear Medicine is used to detect and monitor the progression of cancer, as well as to provide targeted treatments. It is used to detect cancer cells in the body, to measure the effectiveness of cancer treatments, and to provide targeted radiation therapy. Nuclear Medicine can also be used to detect and monitor the spread of cancer to other parts of the body. Nuclear Medicine is used in combination with other treatments, such as chemotherapy and surgery, to provide a comprehensive approach to cancer care. It is also used to provide palliative care, to reduce pain and improve quality of life for cancer patients. Nuclear Medicine is a rapidly growing field, with new technologies and treatments being developed to improve the diagnosis and treatment of cancer. Companies in the Nuclear Medicine market include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Toshiba Medical Systems. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.